NFKB1 and B-cell chronic lymphocytic leukemia: In order to get a more direct evidence about the action of deguelin on the AKT/NFκB pathway in CLL cells we treated 2 additional CLL samples with deguelin, fludarabine or both, alone or in the presence of Ltk- or 3T3-CD40LG.